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Abstract Estrogens rapidly regulate neuronal activity
within seconds-to-minutes, yet it is unclear how estrogens
interact with neural circuits to rapidly coordinate behavior.
This study examines whether 17-beta-estradiol interacts
with an opioidergic network to achieve rapid modulation of
a vocal control circuit. Adult plainWn midshipman Wsh emit
vocalizations that mainly diVer in duration, and rhythmic
activity of a hindbrain–spinal vocal pattern generator (VPG)
directly establishes the temporal features of midshipman
vocalizations. VPG activity is therefore predictive of natural
calls, and ‘Wctive calls’ can be elicited by electrical microsti-
mulation of the VPG. Prior studies show that intramuscular
estradiol injection rapidly (within 5 min) increases Wctive
call duration in midshipman. Here, we delivered opioid
antagonists near the VPG prior to estradiol injection. Rapid
estradiol actions on Wctive calling were completely sup-
pressed by the broad-spectrum opioid antagonist naloxone
and the mu-opioid antagonist beta-funaltrexamine, but were
unaVected by the kappa-opioid antagonist nor-binaltorphi-
mine. Unexpectedly, prior to estradiol administration, all
three opioid antagonists caused immediate, transient
reductions in Wctive call duration. Together, our results indi-
cate that: (1) vocal activity is modulated by opioidergic
networks, conWrming hypotheses from birds and mammals,
and (2) the rapid actions of estradiol on vocal patterning
depend on interactions with a mu-opioid modulatory network.
Keywords Nongenomic · Extranuclear · Membrane · 
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Introduction
Estrogens rapidly regulate behavior within minutes in a
variety of contexts, most notably the sexual behavior of
male rats (Cross and Roselli 1999) and Japanese quail
(Cornil et al. 2006b). Estrogens also act within seconds-to-
minutes on the neurophysiological properties of striatal,
hippocampal and hypothalamic neurons (Qiu et al. 2003;
Woolley  2007). These actions on neuronal excitability
occur via interactions with ion channels and/or neurotrans-
mitter receptors, including those for opioids (reviews: Kelly
and Ronnekleiv 2002; Cornil et al. 2006a). Taken together,
these observations suggest that the mechanisms established
for estrogen action on neuronal activity mediate the rapid
behavioral eVects of estrogens. However, it remains largely
unknown how estrogens rapidly modulate discrete net-
works of neurons that pattern behavioral output. In princi-
ple, estrogen-dependent modulation could be via either
direct eVects on central pattern generators or indirect eVects
on aVerent modulatory networks.
17--Estradiol (E2) modulates the activity of a vocal
central pattern generator in a sound-producing teleost Wsh,
the plainWn midshipman (Porichthys  notatus) (Remage-
Healey and Bass 2004, 2007). Male midshipman establish
and defend nests they build under rocky shelters, and emit
long-duration (>1 min) advertisement calls known as
“hums” to attract females to their nests. Adults of both
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sexes emit short-duration (»100 ms) “grunts” during
aggressive encounters (Brantley and Bass 1994; Bass and
McKibben 2003). The rhythmic activity of hindbrain–spi-
nal vocal pattern generator (VPG; see Fig. 1) directly estab-
lishes the fundamental frequency and duration of
midshipman calls (Bass and Baker 1990). The output of the
VPG (‘Wctive calls’) can be evoked by excitation of mid-
brain and hindbrain sites (Bass and Baker 1990; Weeg et al.
2005; Kittelberger et al. 2006), and the temporal Wring
properties of the VPG directly establish the temporal fea-
tures of natural calls (Bass and Baker 1990). Intramuscular
E2 injection rapidly (within 5 min) increases the duration of
Wctive calls in adult male and female midshipman
(Remage-Healey and Bass 2004, 2007), and these eVects
are both short-lived (lasting 30–45 min) and stereospeciWc.
Androgens and glucocorticoids also cause rapid changes in
Wctive calling in this species and candidate receptor mecha-
nisms have been identiWed by blocking these acute eVects
with cyproterone acetate (antiandrogen) and RU486
(antiglucocorticoid), respectively (Remage-Healey and
Bass 2004). A similar candidate receptor mechanism has
not yet been identiWed for the rapid eVects of E2. The rapid
actions of E2 are localized to the hindbrain–spinal region
that contains the VPG (Remage-Healey and Bass 2004), but
whether E2 acts directly on the VPG itself, or via indirect
actions on neurons that modulate the VPG, is unknown.
The midshipman model system therefore presents an
opportunity to identify mechanism(s) of acute estrogen
action on a deWned neural circuit (shared by all major
vertebrate lineages, see Bass et al. 2008) that patterns
vocalizations.
Here, we test the hypothesis that an opioidergic network
provides a modulatory mechanism for the rapid actions of
E2 in midshipman. Our focus on opioidergic mechanisms is
related to three previous observations. First, rapid E2
actions on mammalian hypothalamic neurons occur via
interactions with opioidergic systems (Kelly et al. 1992;
Qiu et al. 2003). Second, a membrane-bound receptor that
is proposed to mediate rapid corticosteroid suppression of
clasping behavior in amphibians exhibits opioid-like bind-
ing properties (Evans et al. 2000). Lastly, longer-term (i.e.,
hours to days) interactions between steroids (estrogens and
progestins) and opioidergic neurons have emerged in stud-
ies examining the regulation of sexual receptivity in rodents
(Eckersell et al. 1998; Sinchak and Micevych 2001;
Acosta-Martinez and Etgen 2002). We report results for three
opioid antagonists: naloxone, a broad-spectrum opioid
blocker; beta-funaltrexamine, a blocker speciWc to mu-opioid
neurons in other vertebrates; and nor-binaltorphimine, a
blocker speciWc to kappa-opioid neurons in other verte-
brates (Bodnar and Klein 2006). We note that the receptor
speciWcity of these antagonists has not been fully character-
ized for opioid receptors in teleosts, but that opioid receptor
subtypes are broadly conserved among vertebrates (Brooks
et al. 1994; Ebbesson et al. 1996; Khalap et al. 2005, see
discussion).
Materials and methods
Animals
Midshipman Wsh have two adult male morphs that diverge
in a large suite of traits including reproductive tactics and
vocal behaviors (Brantley and Bass 1994). Type I males
build and guard nests in the intertidal zone, whereas smaller
type II males sneak and satellite spawn in attempt to steal
fertilizations from type I’s. Only type I males are known to
produce the long-duration advertisement hums as well as
extended trains of brief agonistic grunts and growls that are
intermediate in duration between hums and grunts (Bass
and McKibben 2003). Type II males and females are only
known to generate grunts in non-spawning contexts. This
study included 40 type I males (13–20 cm standard length)
collected from nest sites in northern California and Wash-
ington state. While females have the highest plasma E2 lev-
els, detectable levels of circulating E2 are found in close to
70% of type I males during pre-nesting and nesting periods
(Sisneros et al. 2004). Also, aromatase-containing glial
cells surround the dorsolateral aspect of the vocal motor
nucleus (VMN) and have processes that ramify throughout
the VMN which likely provide a local source of E2 via aro-
matization of circulating testosterone (Forlano et al. 2001;
Sisneros et al. 2004).
Evoked activity of the vocal pattern generator (VPG)
Electrophysiology procedures closely followed those out-
lined in earlier studies with midshipman Wsh (Bass and
Baker 1990; Goodson and Bass 2000; Remage-Healey and
Bass 2004). The brain and rostral spinal cord were exposed
by dorsal craniotomy under general anesthesia (0.025% ben-
zocaine; Sigma) and long-lasting analgesia (0.25% bupiva-
caine; Abbott Laboratories, Chicago, IL; with 0.01 mg/mg
epinephrine; International Medication Systems, El Monte,
CA). Following surgery, Wsh were stabilized in a plexiglass
tank during recovery and perfused through the mouth with
fresh saltwater maintained at 17°C with a Peltier device.
Exposed brain areas were covered with Flouroinert (3 M
Corp., St. Paul, MN), and intramuscular injections of pancu-
ronium bromide (0.5 mg/kg; Astra Pharmaceutical Products,
Westborough MA) were used for immobilization. Brief
electrical stimuli (pulse width = 0.1 ms, frequency =
250 Hz, duration = 25 ms) were delivered via an insulated
tungsten electrode exposed at the tip (Fig. 1b) to a hind-
brain–spinal vocal site VPP (Bass et al. 2008), formerlyJ Comp Physiol A (2010) 196:137–146 139
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designated as VM (Bass et al. 1994), that is vocally active
(Remage-Healey and Bass 2004; 2006). Electrically evoked
vocal motor volleys were recorded with an extracellular
electrode (TeXon-coated silver wire with exposed ball tip)
placed on a ventral occipital nerve root that carries vocal
motor axons to the ipsilateral vocal muscle attached to the
lateral walls of the swim bladder (Fig. 1b). Activity recorded
from either left- or right-side occipital nerve root reXects
bilateral output (Bass and Baker 1990). Rhythmic vocal
motor volleys occurred as discrete bursts (Wctive calls,
Fig. 1a–c) similar to natural grunts (see Brantley and Bass
1994) and were recorded at 1-s intervals. Recordings were
digitized on a Macintosh using IGOR Pro software (Wave-
metrics, Inc., Lake Oswego, OR). The duration of each
Wctive call was measured from the recordings and the mean
burst duration was computed for each time point and nor-
malized to 100% of baseline output.
Delivery of opioid antagonists
All opioid antagonists were obtained from Tocris Biosci-
ence (Ellisville, MO) and dissolved in buVered teleost
Fig. 1 a Schematic of the experimental timeline for opioid antagonist
infusion (‘spritz’) followed by estradiol (E2) injection, as indicated by
vertical arrows. Each vertical line on the time axis represents an extra-
cellular recording sample; parentheses indicate recording sample
times during the post-spritz period. b Sagittal line drawing of the
midshipman brain, showing the major nuclei in the descending vocal
control system (Bass et al. 1994; Goodson and Bass 2002). The hind-
brain–spinal vocal pattern generator (VPG) consists of a vocal motor
nucleus (VMN) that innervates the vocal swimbladder muscles via
occipital nerve roots, an adjacent column of vocal pacemaker neurons
(VPN) which temporally pattern the activity of the VMN, and a rostral
vocal prepacemaker nucleus (VPP). The VPG receives descending
input from vocal–acoustic centers (VAC) in the hindbrain (h), midbrain
(m), and forebrain (f). Electrical microstimulation of the VPP region
(solid electrode) elicits patterned Wctive calls (traces below; illustra-
tions only and not real data) recorded via extracellular electrode
adjacent to the occipital nerve root. Also depicted is the drug delivery
electrode (dashed electrode) within the fourth ventricle. MO medulla
oblongata,  CBL cerebellum,  MD midbrain,  TEL telencephalon.  c–e
Illustrations of three modulatory eVects on midshipman hindbrain–spi-
nal VPG activity. Traces are 250 ms in duration (scale bar 100 ms) and
are depicted for illustration purposes only. c Functional mu- and/or
kappa-opioid circuits within the VPG region are required for baseline
Wctive call duration. d, e Rapid actions of E2 on Wctive call duration re-
quire the presence of functional mu-opioidergic circuits. In the absence
of functional mu-opioid circuits (d) Wctive call duration remains at
baseline. The combined rapid actions of E2 and mu-opioidergic circuits
(e) result in increased Wctive call duration140 J Comp Physiol A (2010) 196:137–146
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Ringer’s (Forster–Taggart) solution (all solutions had pH
between 6.81 and 8.19). Fictive calls evoked from the hind-
brain–spinal VPP region were considered stable when a
single Wctive call was entrained to each stimulus. Once sta-
bility was established, a series of ten Wctive calls was
evoked at 1-s intervals to determine baseline (pre-drug)
vocal motor output. Immediately following the baseline
period, either saline vehicle (n = 4 animals) or one of three
opioid receptor antagonists was pressure injected (see
below) into the hindbrain (fourth) ventricle that directly
borders the VMN (see Fig. 1b) (Bass and Baker 1990; Bass
et al. 1994). Antagonists included the broad-spectrum opi-
oid receptor antagonist naloxone (1, 10, 25 mM; n =6 ,  4 ,  4
animals each, respectively), the mu-speciWc opioid antago-
nist beta-funaltrexamine (1, 10 mM; n = 4 each), and the
kappa-speciWc opioid antagonist nor-binaltorphimine (0.66,
6.6 mM; n = 3 each). Drug doses were based on previous
studies of opioid–steroid interactions (Evans et al. 2000;
Acosta-Martinez and Etgen 2002; Ceccarelli et al. 2004;
Schmitt and Kaufman 2005). The standard dose sequence
(1, 10 mM) was lowered slightly for nor-binaltorphimine
due to limited reagent availability; it is an eVective kappa-
opioid antagonist in both mammalian and non-mammalian
vertebrates (Bradford et al. 2005).
Drugs and vehicle were delivered via a glass micro-
pipette (microWlament 6010 1.0 mm OD, AM Systems, Carls-
borg, WA) with broken tips (18–20 m) using a picospritzer
(Biomedical Engineering, Thornwood, NY). Only one dose
of opioid antagonist or vehicle was used per experiment
(i.e., in each animal). Injection parameters followed those
well-established for this preparation (one pressure pulse per
second at 30 psi and pulse duration of 10 ms for estimated
infusion volume of approximately 0.16 nl; see Goodson and
Bass 2000; Kittelberger et al. 2006). The picospritzer elec-
trode was checked before and immediately following each
experiment to verify that pressure delivery was functional.
A simultaneous recording of ten Wctive calls was obtained
(as above) concurrent with pressure delivery of solutions to
identify any instantaneous eVects of either drug or saline
delivery on vocal motor patterning (see also the experiment
timeline in Fig. 1a). Two subsequent recordings of 15 Wctive
calls were obtained at 5 and 15 min following solution
delivery (all treatments prior to E2 administration; see
Fig. 1a) to determine whether drugs or saline altered vocal
motor patterning. Five minutes after the 15-min post-drug
recording, Wsh were administered an intramuscular injection
(dorsal trunk muscle) of E2 (0.02 mg/kg) via a pre-inserted
23-G butterXy needle. This treatment dose rapidly increases
Wctive call duration (within 5 min and lasting up to 30 min)
in type I male midshipman (Remage-Healey and Bass 2004,
2007). Immediately following the injection, a subsequent
series of 15 Wctive calls were obtained at 5, 15, 30, 45, and
60 min, and each time point was standardized to 100% of
the baseline output. After the last recording, blood samples
were obtained from the gill arch (Remage-Healey and Bass
2004, 2005; Remage-Healey and Bass 2006), and plasma
was analyzed for E2 using enzyme immunoassay (Cayman
Chemical, Ann Arbor, MI, techniques reported previously
in Remage-Healey and Bass 2004, 2005, 2007). Plasma E2
levels were conWrmed to be elevated (mean = 34.52
ng/ml § 8.01 SEM; n = 16) for a subset of animals that
received E2 injections (see also Remage-Healey and Bass
2004).
Analysis
As described above, Wctive call durations were sampled and
standardized to 100% of baseline. Statistical analyses of the
eVects of drugs on Wctive call duration were performed
using Statview 4.57. Repeated-measures ANOVA was per-
formed for data from all treatments for analysis of treat-
ment eVects over time in a within- and between-subjects
design. Tukey’s post hoc tests are reported for between-
subject eVects for comparisons of saline versus drug treat-
ments for P <0 . 0 5 .
Results
Overview
We Wrst show that each of the opioid antagonists used here—
naloxone, beta-funaltrexamine, and nor-binaltorphimine—
caused a rapid and brief (either immediate or within 5 min of
infusion) suppression of Wctive calling when delivered to the
hindbrain VPP region. All antagonists had similarly brief
eVects when initially applied, but calling recovered to base-
line quickly (within 5–10 min). In contrast, subsequent atten-
uation of rapid E2 e Vects on Wctive calling was both
antagonist-speciWc and prolonged, lasting up to 30–60 min.
This encompasses the duration of E2’s actions on Wctive call-
ing in this species (Remage-Healey and Bass 2004, 2007).
Only naloxone and the mu-opioid-speciWc antagonist beta-
funaltrexamine, but not the kappa-opioid antagonist nor-bin-
altorphimine, inhibited E2’s eVects on calling.
Antagonists alone
Naloxone
The broad-spectrum opioid antagonist naloxone (1, 10, and
25 mM) caused a transient reduction in Wctive call duration,
in a dose-dependent manner (Fig. 2a). There were signiW-
cant eVects of time-after-delivery (F = 8.74;  df =3 , 4 2 ;
P = 0.0001), a dose £ time interaction (F =3 . 3 6 ;   df =9 . 4 2 ;
P = 0.003), and a non-signiWcant trend for the eVect of doseJ Comp Physiol A (2010) 196:137–146 141
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(F =3 . 1 2 ;  df = 3,14;  P = 0.06). Tukey’s post hoc test
revealed that naloxone produced signiWcant (P < 0.05)
reductions in Wctive call duration at 5 min after delivery for
all three doses (1, 10, 25 mM) when compared to saline
alone. Fictive call duration was indistinguishable from
baseline at 15 min following naloxone treatment. For the
5-min time point, the response to naloxone was linearly
dose-dependent; i.e., there was a larger reduction in Wctive
call duration as the doses of naloxone increased.
Beta-funaltrexamine
The mu-speciWc opioid antagonist beta-funaltrexamine (1,
10 mM) also caused a transient reduction in Wctive call
duration (Fig. 2b). There were signiWcant eVects of time-
after-delivery (F = 3.69; df = 3.27; P = 0.04), a dose £ time
interaction (F = 5.55; df = 6.27; P = 0.0007), and no signiW-
cant eVect of dose (F = 1.21;  df =2 . 9 ;  P = 0.34). Tukey’s
post hoc test revealed that beta-funaltrexamine produced sig-
niWcant (P < 0.05) reductions in Wctive call duration immedi-
ately upon delivery (‘spritz’; 10 mM dose) and at 5 min after
delivery (1 mM dose) when compared to saline alone. While
the time-dependence of the response to beta-funaltrexamine
diVered slightly for the two doses, they were similar in tem-
poral pattern. That is, the larger dose (10 mM) produced only
an immediate reduction in Wctive calling and the lower dose
(1 mM) produced a reduction only at 5 min after delivery of
the drug; each recovered to baseline by the next time point
tested, i.e., within at least 5 min (10 mM) or 10 min (1 mM).
Fictive call duration was indistinguishable from baseline at
15 min following beta-funaltrexamine treatment.
Nor-binaltorphimine
The kappa-speciWc opioid antagonist nor-binaltorphimine
(0.66, 6.6 mM) also caused a transient reduction in Wctive
call duration that was, like naloxone, dose-dependent
(Fig. 2c). There were signiWcant eVects of time-after-delivery
(F = 11.43; df = 3.21; P = 0.0001), a dose £ time interac-
tion (F = 11.91;  df =6 . 2 1 ;  P < 0.0001), and a signiWcant
eVect of dose (F =2 9 . 7 ;   df =2 . 7 ;   P = 0.0004). Tukey’s post
hoc test revealed that nor-binaltorphimine produced signiW-
cant (P < 0.05) reductions in Wctive call duration immedi-
ately upon delivery (0 min; 6.6 mM dose) and at 5 min after
delivery (0.66 and 6.6 mM doses) when compared to saline
alone. Fictive call duration was indistinguishable from
baseline at 15 min following nor-binaltorphimine treat-
ment. Similar to beta-funaltrexamine, the dose-dependence
of the response to nor-binaltorphimine was apparent in that
only the highest dose (6.6 mM) produced an immediate
reduction in Wctive calling. Unlike beta-funaltrexamine,
both low and high doses produced reductions in Wctive call-
ing at the 5-min time point. Similar to both naloxone and
beta-funaltrexamine, Wctive call suppression that was pres-
ent at 5 min recovered to baseline at the next time point
tested, i.e., 15 min after picospritzing the drug.
Antagonists together with E2
Naloxone
The broad-spectrum opioid antagonist naloxone (1, 10, and
25 mM) caused suppression of E2’s rapid eVects on Wctive
call duration that was dose-dependent (Fig. 3a). There were
signiWcant eVects of time-after-injection (F =2 . 4 3 ;
df =5 . 6 0 ;  P =0 . 0 4 ) ,  a  d o s e£ time interaction (F =2 . 2 3 ;
df = 15.60; P = 0.01), and a signiWcant eVect of naloxone
dose (F =5 . 3 3 ;   df =3 . 1 2 ;   P = 0.01) when comparing
naloxone + E2 treatments versus saline + E2 treatment.
Tukey’s post hoc test revealed that naloxone + E2 treat-
ments produced signiWcantly shorter Wctive call duration
from saline + E2 treatment at 5 min (10 and 25 mM),
Fig. 2 Interocerebroventricular microinjection of opioid antagonists
rapidly reduce Wctive call duration in midshipman. The broad-spec-
trum opioid antagonist naloxone (a) the mu-speciWc-opioid antagonist
beta-funaltrexamine (b) and the kappa-speciWc-opioid antagonist nor-
binaltorphimine (c) each transiently suppress Wctive call duration. All
treatment eVects recover to baseline at 15 min. *P < 0.05 for Tukey’s
post hoc test for between-subject comparisons of Wctive calling during
infusion of antagonists versus vehicle (saline)142 J Comp Physiol A (2010) 196:137–146
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15 min (25 mM), and 30 min (10 and 25 mM). Therefore,
only the intermediate (10 mM) and high (25 mM) doses of
naloxone were eVective in suppressing the rapid actions of
E2.
Beta-funaltrexamine
The mu-speciWc opioid antagonist beta-funaltrexamine (1,
10 mM) also suppressed E2’s rapid eVects on Wctive call
duration (Fig. 3b). There was no signiWcant eVect of time-
after-injection (F =0 . 6 8 ;   df =5 . 4 5 ;   P = 0.64), but there was
a signiWcant dose £ time interaction (F =3 . 4 4 ;  df =1 0 . 4 5 ;
P = 0.002) and a signiWcant eVect of beta-funaltrexamine
dose (F = 4.26; df =2 . 9 ;  P = 0.05) when comparing beta-
funaltrexamine + E2 treatments versus saline + E2 treat-
ment. Like naloxone, Tukey’s post hoc test revealed that
beta-funaltrexamine + E2 treatments produced signiWcantly
shorter Wctive call duration from saline + E2 treatment at
5 min (1 and 10 mM), 15 min (1 mM), and 30 min (1 mM).
Thus, unlike naloxone, only the low (1 mM) dose of beta-
funaltrexamine was eVective in suppressing the entire time-
course of rapid E2 actions, while the response to the high
(10 mM) dose was no longer signiWcantly diVerent from the
saline + E2 treatment after 15 min.
Nor-binaltorphimine
Unlike naloxone and beta-funaltrexamine, the kappa-spe-
ciWc antagonist nor-binaltorphimine (0.66, 6.6 mM) had no
signiWcant eVect on the rapid increase in Wctive call dura-
tion induced by E2 (Fig. 3c). There was a signiWcant eVect
of time-after-injection (response to E2;  F =1 0 . 7 0 ;
df =5 . 3 5 ;  P < 0.0001), but there was no time £ dose inter-
action (F =0 . 5 7 ;  df =1 0 . 3 5 ;  P = 0.83), and no signiWcant
eVect of binaltorphimine dose (F =0 . 4 2 ;   df =2 . 7 ;   P = 0.67)
when comparing nor-binaltorphimine + E2 treatments versus
saline + E2 treatment. Tukey’s post hoc test did not detect
signiWcant diVerences between nor-binaltorphimine + E2 and
saline + E2 treatment for any time point at any dose. It is
possible that a higher dose of nor-binaltorphimine would
have caused suppression of Wctive calling. However, the
current dose regimen matched the order of magnitude for
the other opioid antagonists used in this study (micro- to
milli-molar range) and is within the high-range of doses for
eVective kappa-opioid blockade as reported in the literature
(Gogas et al. 1996; Mitchell et al. 2005; Bodnar and Klein
2006; Pascoe et al. 2008).
Discussion
This study reports that intracerebroventricular microinjec-
tion of opioid antagonists can acutely inhibit Wctive calling
in midshipman Wsh. We also report that the rapid neuro-
modulation of Wctive calling by E2 is suppressed during
speciWc inhibition of a central mu-opioidergic network. Our
Wndings are therefore consistent with the hypothesis that
rapid E2 actions on hindbrain–spinal VPG activity occur via
interactions with a central mu-opioidergic network whose
activation, in turn, modulates the VPG (as summarized in
Fig. 1).
Opioidergic network and vocal mechanisms
This study provides evidence that opioids are neuromodula-
tory in contexts outside of their well-established role in regu-
lating nociception and reinforcement/reward via actions in
the forebrain (Bodnar and Klein 2006). The current obser-
vation that opioidergic neurons are involved in modulating
vocal motor mechanisms may not be unique to midshipman
Fig. 3 Pre-treatment with mu-opioid antagonists suppresses the rapid
actions of 17--estradiol (E2) on Wctive calling in midshipman. The
broad-spectrum opioid antagonist naloxone (a) and the mu-opioid-spe-
ciWc antagonist beta-funaltrexamine (b) each signiWcantly suppress the
acute increase in Wctive call duration following E2 injection at 5, 15
and 30 min. In contrast, the kappa-opioid-speciWc antagonist nor-bin-
altorphimine (c) produces no eVect on the rapid actions of E2, indicat-
ing that the observed actions are mu-opioid-speciWc. *P <0 . 0 5  f o r
Tukey’s post hoc test for between-subject comparisons of Wctive call-
ing during infusion of antagonists versus vehicle (saline)J Comp Physiol A (2010) 196:137–146 143
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Wsh, since opioids and their receptors are expressed
throughout the song-control pathway in oscine (Deviche
et al. 1993) and non-oscine (Durand et al. 1998) songbirds.
Furthermore, opioids regulate vocal behaviors in both song-
birds and mammals (Riters et al. 2005; Bodnar and Klein
2006), and, consistent with these earlier observations, the
current study provides neurophysiological evidence that
opioidergic neurons participate in the patterning of
vocalizations.
Both the mu-speciWc (beta-funaltrexamine) and the
kappa-speciWc (nor-binaltorphimine) opioid antagonists
caused immediate suppression of Wctive call duration dur-
ing infusion (‘spritz’; latency < 1 min), whereas the broad-
spectrum opioid antagonist naloxone caused vocalization
suppression after a latency of 5 min. Therefore, suppression
was common to all three antagonists as was a rapid recov-
ery to baseline. Relative to the other antagonists, the nalox-
one eVect was delayed but similarly short-lived, which may
relate to diVerences in the ability of each drug to penetrate
neural tissue due to chemical structure or potency (see also
Martin et al. 2006; Chaijale et al. 2008). It is noteworthy
that the binding aYnity of opioid antagonists to mu- and
kappa-opioid receptors have been well-characterized for
mammals, but not yet for teleost Wshes. A lack of strict
dose-dependence for these opioid antagonist treatments on
Wctive calling makes non-speciWc eVects of microinjection
(such as concentration-dependent changes in pH or other
interfering substances) unlikely. However, we cannot for-
mally rule out the possibility of immediate and non-speciWc
artifacts of microinjection on vocal motor network proper-
ties given that all of the antagonists, in general, suppress
Wctive call duration.
Opioid peptide and receptor expression in the midship-
man central nervous system is currently un-described. Opi-
oids and their receptors are highly conserved among
vertebrates (Khalap et al. 2005), and neuroanatomical evi-
dence for opioid networks exist for other teleost Wshes
(Brooks et al. 1994; Ebbesson et al. 1996). In coho salmon,
mu-opioid binding sites are reported throughout the telen-
cephalon, diencephalon and mesencephalon (Ebbesson
et al. 1996), but the distribution of mu-opioid binding sites
in the hindbrain are currently unknown in any teleost
(delta-opioid receptors are found in the hindbrain of
zebraWsh, speciWcally in the periventricular zone and abut-
ting the nucleus of the medial longitudinal fasciculus, Port-
eros et al. 1999). The indication that a mu-opioidergic
network is critical for rapid actions of estrogens in midship-
man Wsh is intriguing in light of the observation that brain
mu-opioid systems are the most highly conserved among
vertebrates (Li et al. 1996; Darlison et al. 1997).
Opioidergic neurons that modulate midshipman vocal
patterning could have multiple neuroanatomical origins.
One of the major descending opioid projections in verte-
brates is the midbrain periaqueductal gray (PAG, Behbeh-
ani  1995), a critical node linking forebrain to hindbrain
vocal neurons in midshipman Wsh (see Kittelberger et al.
2006, PAG is part of the mVAC in Fig 1 top) as well as in
mammals (Jurgens 2008). The current Wndings are consis-
tent with the hypothesis that descending opioidergic neu-
rons from the PAG have terminals in the hindbrain–spinal
VPG, and that their activity contributes to the rapid modu-
lation of vocalizations in midshipman. This hypothesis pre-
dicts that a subset of the projections from the PAG to the
VPG consist of opioidergic processes that are rapid modu-
lated by estrogens (directly or indirectly, see below).
Opioids and rapid estrogen mechanisms
We report that mu-opioidergic antagonists block the rapid
actions of E2 during a 15–60 min period after microinjec-
tion into the hindbrain ventricle adjacent to the VPG. This
indicates that opioid blockers exert long-lasting eVects on
the VPG comprised of mechanisms that could be substan-
tially diVerent from the immediate (0–5 min) inhibitory
eVects of opioid blockers on Wctive calls. Opioid agonists
and antagonists are known to have delayed (minutes-
to-hours) modulatory actions on network function (Brown
et al.  1998), which consist of mechanisms distinct from
rapid opioidergic (seconds-to-minutes) actions on neural
activity (Heinricher 2003; Nugent et al. 2007). The current
results suggest that similarly divergent acute versus delayed
opioid mechanisms can each exert modulatory inXuences
on the VPG circuit in midshipman.
One mechanism to account for the current Wndings is
that opioid antagonists broadly suppress neuronal activity,
including activity within the VPG, and that this suppression
precludes the rapid actions of E2 on the VPG. Consistent
with this hypothesis, opioid agonists and antagonists exert
long-lasting suppression of activity within neural circuits in
a variety of contexts (Bennett and Mayer 1979; Cheng et al.
1986; Charpak et al. 1988). However, in the current experi-
ments, the midshipman VPG recovered from suppression
(i.e., returned to 100% of baseline Wctive calling) within
5–10 min following treatment with all three opioid receptor
antagonists. Secondly, mu-opioid blockade suppressed
baseline VPG activity (Fig. 2b) and subsequent rapid E2
actions (Fig. 3b), yet kappa-opioid blockade only rapidly
suppressed VPG activity (Fig. 2c), but did not subsequently
inXuence E2’s rapid actions (Fig. 3c). These Wndings
together indicate that there are speciWc modulatory interac-
tions between E2 and a candidate mu-opioidergic network
in the midshipman VPG region.
The candidate cellular mechanism(s) for combined
E2/mu-opioid regulation of the VPG include either E2 binding
directly to opioid receptors (Gutierrez et al. 1998), or to
nonclassical binding sites on opioidergic neurons (Lagrange144 J Comp Physiol A (2010) 196:137–146
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et al. 1997). These nonclassical actions of E2 could occur
either directly on modulatory mu-opioidergic neurons, or
indirectly via an as yet unidentiWed modulatory input aVer-
ent to mu-opioidergic neurons. The acute nature of our Wnd-
ings indicate that the site of rapid E2 action within the VPG
region is a nonclassical estrogen-binding site. Although the
selective estrogen-receptor modulator ICI 182,780 potently
blocks long-term estrogen-receptor mechanisms in other tel-
eosts (e.g., Menuet et al. 2005; Pinto et al. 2006a, 2006b),
pilot studies indicate that ICI is ineVective at modulating
E2’s rapid actions on vocal patterning in midshipman Wsh
(Remage-Healey and Bass, unpublished observations). The
binding site which mediates rapid E2 eVects in midshipman
may therefore be structurally dissimilar to the nuclear estro-
gen receptor (i.e., a membrane receptor/ion channel); alter-
natively, the rapid actions of E2 could be mediated by
nonclassical mechanisms associated with the canonical
cytosolic estrogen receptor(s) (e.g., Vasudevan et al. 2005).
Previous evidence from rats indicates that E2 increases the
availability of mu-opioid receptors in hypothalamic inhibi-
tory neurons (Torres-Reveron et al. 2009), suggesting that
the rapid eVects of E2 observed here could be via similarly
nonclassical interactions with hindbrain/spinal GABAergic
neurons that are mu-opioid responsive. Although more
neuroanatomical evidence is needed for teleosts, E2 can
modulate opioidergic function in the brainstem of rats (Tashiro
et al. 2008) and opioid receptor mRNA is co-localized with
estrogen-receptor positive cells in brainstem circuits (Flores
et al. 2003).
The rapid E2/opioidergic modulation reported here is a
part of a growing number of reports indicating that steroids
interact with opioidergic systems to achieve rapid actions
on neuronal activity. Steroids and steroidal drugs interact
directly with opioid receptors, including mu-opioid recep-
tors, to alter binding aYnities for endogenous opioids and
subsequent neuronal activity (Maggi et al. 1996; SanMartin
et al. 1999; Sajadi et al. 2007; Brown et al. 2008). A mem-
brane glucocorticoid receptor recently isolated in newts
exhibits kappa-opioid binding properties, and has been pro-
posed to mediate the rapid actions of corticosterone on
reproductive clasping behavior (Evans et al. 2000). In
guinea pig hypothalamus, E2 rapidly inhibits the mu-opioid
eVector system (Kelly et al. 1992), although not via a direct
interaction with opioid receptors per se (Qiu et al. 2003). In
contrast, in rat hypothalamus, E2 causes mu-opioid receptor
traYcking inward from the membrane (internalization)
within 30 min, and this eVect can be blocked by treatment
with the broad-spectrum opioid blocker naltrexone (Ecker-
sell et al. 1998; Sinchak and Micevych 2001). Micevych
and colleagues have proposed that E2 causes rapid release
of opioid peptides, which then bind to mu-opioid receptors,
leading to their internalization. The results of the current
study are consistent with this model from rat hypothalamus,
and support the hypothesis that the rapid eVects of E2 cause
the release of mu-opioids within the VPG and thereby
increase Wctive call duration. This model for the midship-
man VPG generates two speciWc predictions: (1) opioider-
gic modulatory neurons express estrogen-binding sites,
most likely presynaptically within the VPG itself, and (2)
estrogen treatment will lead to rapid increases in local
mu-opioid concentrations accompanied by rapid internalization
of mu-opioid receptors in the VPG region of midshipman.
This study demonstrates that steroids and neuropeptides
can interact in the minute-by-minute control of motor net-
work patterning, suggesting that acute shifts in midshipman
calling behavior in nature involve combined rapid actions
of estrogens and opioids (Fig. 1). Our Wndings are consis-
tent with a mechanism of second-order, or “meta”-modula-
tion, in which the actions of one neuromodulator (in this
case E2) inXuence the actions of an existing neuromodula-
tory circuit (in this case mu-opioid neurons). Metamodula-
tion provides an important mechanism for generating a
broad range of behavioral states from a discrete network of
neurons (Katz and Edwards 1999; Mesce 2002; McLean
and Sillar 2004). Metamodulation is likely an important
mechanism for shaping vocal output in midshipman, since
the neuropeptides arginine vasotocin and isotocin also exert
rapid actions on Wctive calling in this species (Goodson and
Bass 2000).
The current results suggest that the steroid-sensitive
neural circuitry that patterns vocal production in other ver-
tebrates (Schlinger and Brenowitz 2002; Bass and Remage-
Healey 2008; Jurgens 2008), could be regulated by acute
steroid/opioid interactions similar to those in this study.
Thus far, evidence has been suggestive in favor of this
hypothesis. Masculinization of “crow” vocalizations in
quail involves a testosterone-dependent upregulation of
opioid binding sites in the brainstem (Bernroider et al.
1996). In addition, peripheral injections of opioid receptor
antagonists increase male song production in starlings
(Riters et al. 2005). However, to our knowledge neuro-
physiological evidence that opioids and steroids interact to
regulate vocal patterning does not exist for birds and
mammals. The mammalian hypothalamus exhibits sexually
dimorphic expression of opioid peptides, and some neurons
co-express mRNA for steroid receptors and opioids
(Gu and Simerly 1994; Roepke et al. 2007). Therefore,
rapid interactions between opioid- and steroid-dependent
mechanisms, such as those outlined in this study, could be
especially important for sex diVerences in brain function
and behavioral plasticity in vertebrates.
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